Opioid harm reduction strategies: focus on expanded access to intranasal naloxone

Pharmacotherapy. 2010 Jul;30(7):627-31. doi: 10.1592/phco.30.7.627.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Intranasal
  • Harm Reduction
  • Humans
  • Naloxone / administration & dosage*
  • Narcotic Antagonists / administration & dosage*

Substances

  • Narcotic Antagonists
  • Naloxone